Skip to main navigation Skip to main content

CEEM : Clinical and Experimental Emergency Medicine

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Original Article
Critical Care

The mortality of patients with sepsis increases in the first month of a new academic year

Clinical and Experimental Emergency Medicine 2024;11(2):161-170.
Published online: January 29, 2024

1Department of Emergency Medicine, Korea University Ansan Hospital, Ansan, Korea

2Department of Emergency Medicine, Korea University Guro Hospital, Seoul, Korea

Correspondence to: Jong-Hak Park Department of Emergency, Korea University Ansan Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan 15355, Korea Email: roadrunner@korea.ac.kr
• Received: August 28, 2023   • Revised: October 31, 2023   • Accepted: October 31, 2023

Copyright © 2024 The Korean Society of Emergency Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).

  • 7,259 Views
  • 105 Download
  • 1 Web of Science
  • 1 Crossref
  • 1 Scopus
prev next

Citations

Citations to this article as recorded by  Crossref logo
  • Illness severity modifies the association between sepsis and survival in critically ill patients with acute kidney injury
    Mahnaz Derakhshan, Mory Ghomshei, Hamid Reza Ansarian
    Clinical and Experimental Nephrology.2026; 30(4): 581.     CrossRef

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

The mortality of patients with sepsis increases in the first month of a new academic year
Clin Exp Emerg Med. 2024;11(2):161-170.   Published online January 29, 2024
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
The mortality of patients with sepsis increases in the first month of a new academic year
Clin Exp Emerg Med. 2024;11(2):161-170.   Published online January 29, 2024
Close

Figure

  • 0
  • 1
  • 2
  • 3
  • 4
The mortality of patients with sepsis increases in the first month of a new academic year
Image Image Image Image Image
Fig. 1. Flowchart of the number of included and excluded patients. qSOFA, quick Sepsis-related Organ Failure Assessment; DNAR, do not attempt resuscitation; ED, emergency department.
Fig. 2. Monthly trend for patients with sepsis who visited the hospital between 2018 and 2021. (A) The 30-day mortality rate. (B) The Surviving Sepsis Campaign (SSC) bundle adherence rate.
Fig. 3. Kaplan-Meier curve and log-rank test between the turnover and non-turnover periods. (A) Overall patients with sepsis. (B) Patients with septic shock. (C) Sepsis without shock.
Fig. 4. Subgroup analysis of adjusted hazard ratios (aHRs) for 30-day mortality in the turnover period. Adjusted confounders were age, malignancy, presence of shock, Sepsis-related Organ Failure Assessment (SOFA) score, initial serum lactate, and overall bundle adherence. CI, confidence interval; SBP, systolic blood pressure.
Fig. 5. Monthly trend for patients with sepsis who visited the hospital by year. (A) The 30-day mortality rate. (B) The Surviving Sepsis Campaign (SSC) bundle adherence rate.
The mortality of patients with sepsis increases in the first month of a new academic year
Characteristic Turnover period (n=102) Non-turnover period (n=741) P-value
Male sex 61 (59.8) 429 (57.9) 0.714
Age (yr) 77 (68–85) 77 (66–83) 0.286
Underlying disease
 Diabetes mellitus 39 (38.2) 298 (40.2) 0.702
 Hypertension 49 (48.0) 395 (53.3) 0.318
 Chronic liver disease 8 (7.8) 45 (6.1) 0.490
 Chronic kidney disease 12 (11.8) 90 (12.1) 0.912
 Chronic respiratory disease 16 (15.7) 131 (17.7) 0.619
 Cardiovascular disease 14 (13.7) 142 (19.2) 0.185
 Malignancy 24 (23.5) 162 (21.9) 0.703
Suspected infection source
 Genitourinary infection 36 (35.3) 280 (37.8) 0.626
 Respiratory infection 63 (61.8) 485 (65.5) 0.464
 Gastrointestinal infection 12 (11.8) 63 (8.5) 0.278
 Other infection source 8 (7.8) 44 (5.9) 0.453
 Multiple infection sources 25 (24.5) 185 (25.0) 0.920
Presence of shock 39 (38.2) 259 (35.0) 0.516
Severity
 APACHE II score 20 (15–24) 19 (15–23) 0.339
 SOFA score 9 (6–11) 8 (6–11) 0.245
 Initial serum lactate (mmol/L) 3.5 (1.9–7.3) 2.9 (1.9–5.5) 0.120
Adherence to SSC bundle
 Overall bundle adherence 43 (42.2) 356 (48.0) 0.264
 Fluid administration in 3 hr 68 (66.7) 512 (69.1) 0.620
 Antibiotics administration in 3 hr 73 (71.6) 576 (77.7) 0.166
 Time to antibiotics (min) 129 (71–202) 115 (71–181) 0.140
 Lactate measurement 101 (99.0) 741 (99.6) 0.429
 Lactate follow-up 87 (85.3) 660 (89.1) 0.248
 Time to vasopressor if indicated (min) 137 (45.8–293.5) 132 (67.5–240.0) 0.978
Primary outcome
 7-day Mortality 32 (31.4) 123/736 (16.7) <0.001
 14-day Mortality 44 (43.1) 170/727 (23.4) <0.001
 30-day Mortality 48/98 (49.0) 202/709 (28.5) <0.001
Secondary outcome
 Length of ED stay (min) 689 (488.5–1,330.3) 625 (413.0–1,171.0) 0.114
 Length of hospital stay (day) 11 (4–28) 13 (7–23) 0.213
 Length of ICU stay (day) 8 (4–14) 9 (4–17) 0.386
Variable HR (95% CI) P-value
Sex
 Male 1 (Reference) -
 Female 1.123 (0.874–1.442) 0.365
Age (yr) 1.023 (1.012–1.034) <0.001
Underlying disease
 Diabetes mellitus 1.196 (0.931–1.536) 0.161
 Hypertension 1.000 (0.780–1.282) 0.999
 Chronic liver disease 1.325 (0.839–2.092) 0.228
 Chronic kidney disease 1.008 (0.692–1.469) 0.967
 Chronic respiratory disease 1.242 (0.917–1.682) 0.162
 Cardiovascular disease 0.884 (0.638–1.224) 0.457
 Malignancy 1.970 (1.516–2.561) <0.001
Suspected infection source 0.294
 Genitourinary infection 1 (Reference) -
 Respiratory infection 1.451 (0.975–2.159) 0.066
 Gastrointestinal infection 1.433 (0.750–2.738) 0.277
 Other infection source 1.613 (0.947–2.749) 0.079
 Multiple infection sources 1.571 (1.027–-2.403) 0.037
Presence of shock 3.219 (2.506–4.136) <0.001
Severity
 APACHE II score 1.088 (1.068–1.109) <0.001
 SOFA score 1.171 (1.131–1.211) <0.001
 Initial serum lactate 1.170 (1.139–1.203) <0.001
Admission in turnover period 1.925 (1.405–2.638) <0.001
Adherence to SSC bundle
 Overall bundle adherence 0.775 (0.603–0.997) 0.047
 Fluid administration in 3 hr 0.817 (0.630–1.061) 0.129
 Antibiotics administration in 3 hr 0.878 (0.661–1.166) 0.369
 Lactate follow-up 0.831 (0.568–1.218) 0.343
Variable aHR (95% CI) P-value
Age (yr) 1.026 (1.014–1.037) <0.001
Malignancy 1.758 (1.347–2.293) <0.001
Presence of shock 1.594 (1.143–2.222) 0.006
SOFA score 1.088 (1.041–1.137) <0.001
Initial serum lactate 1.113 (1.077–1.151) <0.001
Overall bundle adherence 0.765 (0.592–0.988) 0.040
Admission in turnover period 1.990 (1.444–2.743) <0.001
Table 1. Comparison of characteristics of patients with sepsis in the turnover and non-turnover periods between 2018 and 2021 (n=843)

Values are presented as number (%) or median (interquartile range).

APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sepsis-related Organ Failure Assessment; SSC, Surviving Sepsis Campaign; ED, emergency department; ICU, intensive care unit.

Table 2. Univariable Cox proportional hazard regression analyses of 30-day mortality

HR, hazard ratio; CI, confidence interval; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sepsis-related Organ Failure Assessment; SSC, Surviving Sepsis Campaign.

Table 3. Multivariate Cox proportional hazard regression analysis of 30-day mortality

aHR, adjusted hazard ratio; CI, confidence interval; SOFA, Sepsis-related Organ Failure Assessment.